Polyglutamine-expanded ataxin-3 activates mitochondrial apoptotic pathway by upregulating Bax and downregulating Bcl-xL

Spinocerebellar ataxia type 3 (SCA3) is an autosomal dominant neurodegenerative disease caused by polyglutamine-expanded ataxin-3. In the present study, we expressed disease-causing mutant ataxin-3-Q79 in neuronal cultures of cerebellum, striatum and substantia nigra by using recombinant adenoviruse...

Full description

Bibliographic Details
Main Authors: An-Hsun Chou, Tu-Hsueh Yeh, Yu-Li Kuo, Yu-Cheng Kao, Mei-Jie Jou, Chia-Yu Hsu, Shu-Ru Tsai, Akira Kakizuka, Hung-Li Wang
Format: Article
Language:English
Published: Elsevier 2006-02-01
Series:Neurobiology of Disease
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0969996105002123
_version_ 1818414529338408960
author An-Hsun Chou
Tu-Hsueh Yeh
Yu-Li Kuo
Yu-Cheng Kao
Mei-Jie Jou
Chia-Yu Hsu
Shu-Ru Tsai
Akira Kakizuka
Hung-Li Wang
author_facet An-Hsun Chou
Tu-Hsueh Yeh
Yu-Li Kuo
Yu-Cheng Kao
Mei-Jie Jou
Chia-Yu Hsu
Shu-Ru Tsai
Akira Kakizuka
Hung-Li Wang
author_sort An-Hsun Chou
collection DOAJ
description Spinocerebellar ataxia type 3 (SCA3) is an autosomal dominant neurodegenerative disease caused by polyglutamine-expanded ataxin-3. In the present study, we expressed disease-causing mutant ataxin-3-Q79 in neuronal cultures of cerebellum, striatum and substantia nigra by using recombinant adenoviruses. Subsequently, SCA3 cellular model was used to investigate the molecular mechanism by which ataxin-3-Q79 causes neuronal death. TUNEL staining studies showed that ataxin-3-Q79 induced apoptotic death of cerebellar, striatal or substantia nigra neurons. Ataxin-3-Q79 activated caspase-3 and caspase-9 without inducing the formation of active caspase-8. Ataxin-3-Q79 promoted mitochondrial release of cytochrome c and Smac, which was preceded by the upregulation of Bax protein and downregulation of Bcl-xL protein expression. Real-time TaqMan RT-PCR assays demonstrated that ataxin-3-Q79 upregulated Bax mRNA level and downregulated Bcl-xL mRNA expression in striatal, cerebellar and substantia nigra neurons. Our results suggest that polyglutamine-expanded ataxin-3-Q79 activates mitochondrial apoptotic pathway and induces neuronal death by upregulating Bax expression and downregulating Bcl-xL expression.
first_indexed 2024-12-14T11:20:33Z
format Article
id doaj.art-e776351009d2461f9297d9314b6e34e4
institution Directory Open Access Journal
issn 1095-953X
language English
last_indexed 2024-12-14T11:20:33Z
publishDate 2006-02-01
publisher Elsevier
record_format Article
series Neurobiology of Disease
spelling doaj.art-e776351009d2461f9297d9314b6e34e42022-12-21T23:03:46ZengElsevierNeurobiology of Disease1095-953X2006-02-01212333345Polyglutamine-expanded ataxin-3 activates mitochondrial apoptotic pathway by upregulating Bax and downregulating Bcl-xLAn-Hsun Chou0Tu-Hsueh Yeh1Yu-Li Kuo2Yu-Cheng Kao3Mei-Jie Jou4Chia-Yu Hsu5Shu-Ru Tsai6Akira Kakizuka7Hung-Li Wang8Department of Anesthesiology, Chang Gung Memorial Hospital, Taiwan, ROC; Graduate Institute of Clinical Medical Science, Chang Gung University School of Medicine, Kwei-San, Tao-Yuan, Taiwan, ROCDepartment of Neurology, Chang Gung Memorial Hospital, Taiwan, ROC; Graduate Institute of Clinical Medical Science, Chang Gung University School of Medicine, Kwei-San, Tao-Yuan, Taiwan, ROCDepartment of Physiology, Chang Gung University School of Medicine, Kwei-San, Tao-Yuan, Taiwan, ROCDepartment of Physiology, Chang Gung University School of Medicine, Kwei-San, Tao-Yuan, Taiwan, ROCDepartment of Pharmacology, Chang Gung University School of Medicine, Kwei-San, Tao-Yuan, Taiwan, ROCDepartment of Physiology, Chang Gung University School of Medicine, Kwei-San, Tao-Yuan, Taiwan, ROCDepartment of Physiology, Chang Gung University School of Medicine, Kwei-San, Tao-Yuan, Taiwan, ROCGraduate School of Biostudies, Kyoto University, Kyoto, JapanDepartment of Physiology, Chang Gung University School of Medicine, Kwei-San, Tao-Yuan, Taiwan, ROC; Corresponding author. Fax: +886 3 221 8700.Spinocerebellar ataxia type 3 (SCA3) is an autosomal dominant neurodegenerative disease caused by polyglutamine-expanded ataxin-3. In the present study, we expressed disease-causing mutant ataxin-3-Q79 in neuronal cultures of cerebellum, striatum and substantia nigra by using recombinant adenoviruses. Subsequently, SCA3 cellular model was used to investigate the molecular mechanism by which ataxin-3-Q79 causes neuronal death. TUNEL staining studies showed that ataxin-3-Q79 induced apoptotic death of cerebellar, striatal or substantia nigra neurons. Ataxin-3-Q79 activated caspase-3 and caspase-9 without inducing the formation of active caspase-8. Ataxin-3-Q79 promoted mitochondrial release of cytochrome c and Smac, which was preceded by the upregulation of Bax protein and downregulation of Bcl-xL protein expression. Real-time TaqMan RT-PCR assays demonstrated that ataxin-3-Q79 upregulated Bax mRNA level and downregulated Bcl-xL mRNA expression in striatal, cerebellar and substantia nigra neurons. Our results suggest that polyglutamine-expanded ataxin-3-Q79 activates mitochondrial apoptotic pathway and induces neuronal death by upregulating Bax expression and downregulating Bcl-xL expression.http://www.sciencedirect.com/science/article/pii/S0969996105002123Spinocerebellar ataxia type 3Ataxin-3Polyglutamine-expanded ataxin-3ApoptosisPolyglutamine neurodegenerative disordersBax
spellingShingle An-Hsun Chou
Tu-Hsueh Yeh
Yu-Li Kuo
Yu-Cheng Kao
Mei-Jie Jou
Chia-Yu Hsu
Shu-Ru Tsai
Akira Kakizuka
Hung-Li Wang
Polyglutamine-expanded ataxin-3 activates mitochondrial apoptotic pathway by upregulating Bax and downregulating Bcl-xL
Neurobiology of Disease
Spinocerebellar ataxia type 3
Ataxin-3
Polyglutamine-expanded ataxin-3
Apoptosis
Polyglutamine neurodegenerative disorders
Bax
title Polyglutamine-expanded ataxin-3 activates mitochondrial apoptotic pathway by upregulating Bax and downregulating Bcl-xL
title_full Polyglutamine-expanded ataxin-3 activates mitochondrial apoptotic pathway by upregulating Bax and downregulating Bcl-xL
title_fullStr Polyglutamine-expanded ataxin-3 activates mitochondrial apoptotic pathway by upregulating Bax and downregulating Bcl-xL
title_full_unstemmed Polyglutamine-expanded ataxin-3 activates mitochondrial apoptotic pathway by upregulating Bax and downregulating Bcl-xL
title_short Polyglutamine-expanded ataxin-3 activates mitochondrial apoptotic pathway by upregulating Bax and downregulating Bcl-xL
title_sort polyglutamine expanded ataxin 3 activates mitochondrial apoptotic pathway by upregulating bax and downregulating bcl xl
topic Spinocerebellar ataxia type 3
Ataxin-3
Polyglutamine-expanded ataxin-3
Apoptosis
Polyglutamine neurodegenerative disorders
Bax
url http://www.sciencedirect.com/science/article/pii/S0969996105002123
work_keys_str_mv AT anhsunchou polyglutamineexpandedataxin3activatesmitochondrialapoptoticpathwaybyupregulatingbaxanddownregulatingbclxl
AT tuhsuehyeh polyglutamineexpandedataxin3activatesmitochondrialapoptoticpathwaybyupregulatingbaxanddownregulatingbclxl
AT yulikuo polyglutamineexpandedataxin3activatesmitochondrialapoptoticpathwaybyupregulatingbaxanddownregulatingbclxl
AT yuchengkao polyglutamineexpandedataxin3activatesmitochondrialapoptoticpathwaybyupregulatingbaxanddownregulatingbclxl
AT meijiejou polyglutamineexpandedataxin3activatesmitochondrialapoptoticpathwaybyupregulatingbaxanddownregulatingbclxl
AT chiayuhsu polyglutamineexpandedataxin3activatesmitochondrialapoptoticpathwaybyupregulatingbaxanddownregulatingbclxl
AT shurutsai polyglutamineexpandedataxin3activatesmitochondrialapoptoticpathwaybyupregulatingbaxanddownregulatingbclxl
AT akirakakizuka polyglutamineexpandedataxin3activatesmitochondrialapoptoticpathwaybyupregulatingbaxanddownregulatingbclxl
AT hungliwang polyglutamineexpandedataxin3activatesmitochondrialapoptoticpathwaybyupregulatingbaxanddownregulatingbclxl